BSECompany Update29 Aug 2026 · 29 Aug 2026, 06:53 pm

Newspaper Advertisement of Notice of the 45th Annual General Meeting and e-voting information

Emcure Pharmaceuticals Ltd · 544210

✦ AI SummaryMgmt Change

Emcure Pharmaceuticals Ltd has published a newspaper advertisement for its 45th Annual General Meeting (AGM) and e-voting information, to be held on September 21, 2026, through video conferencing or other audio-visual means.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

361ffc01-c587-406f-971f-6ade8c2c1466.pdf

pdf

Download →
View document text
Emcure Ref: EPL/CS/SE/0077/2026 Date: August 29, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Newspaper Advertisement of Notice of the 45th Annual General Meeting and e-voting Information. Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, please find enclosed herewith copies of newspaper advertisement published in “Financial Express”- all editions (English) and “Loksatta”- Pune edition (Marathi) today i.e. on Saturday, August 29, 2026, which includes the following information: 1. Intimation of 45th Annual General Meeting (“AGM”) of our Company to be held on Monday, September 21, 2026, at 11.00 a.m. (IST) through Video Conferencing (“VC”) / other audio-visual means (“OAVM”) 2. Details of remote e-voting facility provided to the Members of the Company, to enable them to cast their votes on the resolutions proposed to be passed at the AGM. This intimation is also available on the website of the Company: www.emcure.com. You are requested to take the above information on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary & Compliance Officer ICSI Membership Number: A25687 Encl: As above Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251